carvedilol has been researched along with calcimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danihelová, E; Jancinová, V; Májeková, M; Nosál, R; Petríková, M | 1 |
Cupanikova, D; Lojek, A; Macickova, T; Nosal, R; Pecivova, J; Pekarova, M | 1 |
2 other study(ies) available for carvedilol and calcimycin
Article | Year |
---|---|
Antiplatelet activity of carvedilol in comparison to propranolol.
Topics: Adenosine Diphosphate; Calcimycin; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Propanolamines; Propranolol; Reference Values; Tetradecanoylphorbol Acetate | 2002 |
Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
Topics: Adrenergic beta-Antagonists; Androstadienes; Calcimycin; Carbazoles; Carvedilol; Humans; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidants; Peroxidase; Phosphatidylinositol 3-Kinases; Propanolamines; Protein Kinase C; Receptors, Adrenergic, beta; Stimulation, Chemical; Superoxides; Tetradecanoylphorbol Acetate; Wortmannin | 2008 |